Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Meyer, Everett  [Clear All Filters]
2024
Primavera R, Regmi S, Yarani R, Levitte S, Wang J, Ganguly A, Chetty S, Guindani M, Ricordi C, Meyer E, et al. Precision Delivery of Human Bone Marrow-Derived Mesenchymal Stem Cells Into the Pancreas Via Intra-arterial Injection Prevents the Onset of Diabetes. Stem Cells Transl Med. 2024.
2023
Bader CS, Pavlova A, Lowsky R, Muffly L, Shiraz P, Arai S, Johnston LJ, Rezvani AR, Weng W-K, Miklos DB, et al. Single Center Randomized Trial of T-reg graft alone versus T-reg graft Plus Tacrolimus for the Prevention of Acute GVHD. Blood Adv. 2023.
2021
Chen PP, Cepika A-M, Agarwal-Hashmi R, Saini G, Uyeda MJ, Louis DM, Cieniewicz B, Narula M, Hernandez LCAmaya, Harre N, et al. Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients. Sci Transl Med. 2021;13(617):eabf5264.
2020
Erkers T, Xie B, Kenyon LJean, Smith B, Rieck M, Jensen KP, Ji X, Basina M, Strober S, Negrin RS, et al. High-Parametric Evaluation of Human Invariant Natural Killer T Cells to Delineate Heterogeneity in Allo- and Autoimmunity. Blood. 2020.
Marshall PL, Nagy N, Kaber G, Barlow GL, Ramesh A, Xie BJ, Linde MH, Haddock NL, Lester CA, Tran Q-L, et al. Hyaluronan synthesis inhibition impairs antigen presentation and delays transplantation rejection. Matrix Biol. 2020.
Lemieux C, Johnston LJ, Lowsky R, Muffly LS, Craig JK, Shiraz P, Rezvani A, Frank MJ, Weng W-K, Meyer E, et al. Outcomes with Autologous or Allogeneic Stem Cell Transplantation in Patients with Plasma Cell Leukemia in the Era of Novel Agents. Biol Blood Marrow Transplant. 2020.